Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG

  • E Waubant
  • , B Banwell
  • , E Wassmer
  • , MP Sormani
  • , MP Amato
  • , Rogier Hintzen
  • , L Krupp
  • , K Rostasy
  • , S Tenembaum
  • , T Chitnis

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)
15 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)E2538-E2549
JournalNeurology
Volume92
Issue number22
DOIs
Publication statusPublished - 2019

Research programs

  • EMC OR-01

Cite this